Klin Padiatr 2010; 222(7): 464-466
DOI: 10.1055/s-0030-1263144
Case Report

© Georg Thieme Verlag KG Stuttgart · New York

Lemierre Syndrome and Nosocomial Transmission of Fusobacterium Necrophorum From Patient to Physician

Lemierre-Syndrom und nosokomiale Übertragung von Fusobacterium necrophorum von Patient auf ÄrztinJ. Bonhoeffer1 , D. Trachsel2 , J. Hammer2 , E. Nava2 , U. Heininger1
  • 1Paediatric Infectious Diseases and Vaccines, University Children's Hospital Basel, Switzerland
  • 2Paediatric Intensive Care, University Children's Hospital Basel, Switzerland
Further Information

Publication History

Publication Date:
22 September 2010 (online)

Abstract

Background: Human-to-human transmission of Fusobacterium necrophorum has not been described before.

Case presentation: We present the case of a 15-year-old girl with Lemierre Syndrome and possible nosocomial transmission of F. necrophorum to her treating physician in hospital.

Conclusion: Early diagnosis and treatment of anaerobic pharyngitis is critical to prevent Lemierre Syndrome. Respiratory precautions should be recommended to medical staff caring for patients with suspected Lemierre Syndrome to prevent nosocomial transmission.

Zusammenfassung

Hintergrund: Die nosokomiale Übertragung von Fusobacterium necrophorum ist bislang in der Literatur nicht beschrieben.

Fallbeschreibung: Wir berichten über eine 15-jährige Patientin mit Lemierre-Syndrom und möglicher nosokomialer Übertragung von Fusobacterium necrophorum auf ihre behandelnde Ärztin in der Kinderklinik.

Schlussfolgerung: Die frühzeitige Diagnosestellung und adäquate Behandlung der Pharyngitis durch Anaerobier ist wichtig in der Prävention des Lemierre-Syndroms. Ferner sind geeignete Schutzmaßnahmen zu ergreifen, um die nosokomiale Übertragung der Erreger von Patienten auf Gesundheitspersonal zu verhindern.

References

  • 1 Armstrong AW, Spooner K, Sanders JW. Lemierre's syndrome.  Curr Infect Dis Report. 2000;  2 168-173
  • 2 Bondy P, Grant T. Lemierre's syndrome: what are the roles for anticoagulation and long-term antibiotic therapy?.  Ann Otol Rhinol Laryngol. 2008;  117 679-683
  • 3 Eykyn SJ. Necrobacillosis.  Scand J Infect Dis Suppl. 1989;  62 41-46
  • 4 Goldenberg NA, Knapp-Clevenger R, Hays T. et al . Lemierre's and Lemierre's-like syndromes in children: survival and thromboembolic outcomes.  Pediatrics. 2005;  116 e543-e548
  • 5 Hagelskjaer LH, Prag J, Malczynski J. et al . Incidence and clinical epidemiology of necrobacillosis, including Lemierre's syndrome, in Denmark 1990–1995.  Eur J Clin Microbiol Infect Dis. 1998;  17 561-565
  • 6 Hagelskjaer Kristensen L, Prag J. Human necrobacillosis, with emphasis on Lemierre's syndrome.  Clin Infect Dis. 2000;  31 524-532
  • 7 Hochmair M, Valipour A, Oschatz E. et al . From a sore throat to the intensive care unit: the Lemierre syndrome.  Wien Klin Wochenschr. 2006;  118 243-246
  • 8 Karkos PD, Asrani S, Karkos CD. et al . Lemierre's syndrome: A systematic review.  Laryngoscope. 2009;  119 1552-1559
  • 9 Lemierre A. On certain septicaemias due to anaerobic organisms.  Lancet. 1936;  1 701-703
  • 10 Leugers CM, Clover R. Lemierre syndrome: postanginal sepsis.  J Am Board Fam Pract. 1995;  8 384-391
  • 11 Moreno S, Garcia Altozano J, Pinilla B. et al . Lemierre's disease: postanginal bacteremia and pulmonary involvement caused by Fusobacterium necrophorum.  Rev Infect Dis. 1989;  11 319-324
  • 12 Riordan T, Wilson M. Lemierre's syndrome: more than a historical curiosa.  Postgrad Med J. 2004;  80 328-334

Correspondence

Ulrich HeiningerMD 

University Children's Hospital

Basel

Paediatric Infectious Diseases

and Vaccines

PO Box 4005 Basel

Switzerland

Phone: +41/61/685 6528

Fax: +41/61/685 6012

Email: ulrich.heininger@ukbb.ch

    >